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Introduction
The cochlea is a fluid-filled coiled tube found within the inner 
ear, where it plays a central role in mammalian hearing. In response 
to sound, hair bundles located on hair cells within the cochlea 
are deflected, resulting in the opening of mechanosensitive ion 
channels that alter the voltage of the cell membrane. This change 
in membrane potential results in the activation of L-type voltage-
gated calcium channels to allow calcium influx, which trig-
gers synaptic vesicle exocytosis and neurotransmitter release 
(Glowatzki and Fuchs, 2002). This chain of events must occur 
quickly to distinguish temporally between sounds (Rose et al., 
1967). Synapses formed by inner hair cells (IHCs) also contain 
specialized structures called synaptic ribbons that are capable of 
tethering numerous synaptic vesicles at release sites to facilitate 
high rates of sustained synaptic transmission (Liberman, 1980; 
Glowatzki and Fuchs, 2002).
The vesicle fusion step is believed to be mediated by the 
SNARE proteins synapbtobrevin 2, syntaxin 1A, and SNAP-25 
on the vesicle and plasma membranes (Safieddine and Wenthold, 
1999). However, SNAREs are not sensitive to calcium, and in 
reconstituted fusion assays, they mediate fusion on time scales 
that are orders of magnitude slower than observed in vivo (Weber 
et al., 1998). In neurons, calcium sensitivity and fast kinetics are 
typically conferred by SNARE-binding proteins, including   
synaptotagmin I/II (Chapman, 2008). However, mature hair cells 
have little or no synaptotagmin I/II (Safieddine and Wenthold, 
1999), and it has been proposed that the transmembrane protein 
otoferlin might serve as the calcium sensor that regulates hair 
cell neurotransmitter release by accelerating SNARE-mediated 
membrane fusion (Roux et al., 2006).
Otoferlin occurs in multiple splice variants, including a 
1,997–amino acid form, consisting of a transmembrane segment 
and six cytoplasmic C2 domains, and a shorter three–C2 domain 
isoform found in humans but not mice (Yasunaga et al., 2000). 
A role for otoferlin in IHC neurotransmitter release is based on 
several lines of evidence, including the finding that mice lack-
ing otoferlin are profoundly deaf but have intact and functional 
mechanoelectrical transduction processes (Roux et al., 2006). 
These mice also have functional afferent neurons, suggesting that 
otoferlin’s role in the auditory pathway lies within the hair cell   
between the mechanoelectrical transduction and afferent neuron 
activation steps. In support of this idea, hair cells in otoferlin 
knockout mice do not release neurotransmitter in response to 
membrane depolarization and calcium influx, despite having 
apparently normal synapse morphology (Roux et al., 2006).   
O
toferlin is a large multi–C2 domain protein pro­
posed to act as a calcium sensor that regulates 
synaptic vesicle exocytosis in cochlear hair cells. 
Although mutations in otoferlin have been associated with 
deafness, its contribution to neurotransmitter release is un­
resolved. Using recombinant proteins, we demonstrate that 
five of the six C2 domains of otoferlin sense calcium with   
apparent dissociation constants that ranged from 13–25 µM; 
in the presence of membranes, these apparent affinities 
increase by up to sevenfold. Using a reconstituted membrane 
fusion assay, we found that five of the six C2 domains of 
otoferlin stimulate membrane fusion in a calcium­dependent 
manner. We also demonstrate that a calcium binding– 
deficient form of the C2C domain is incapable of stimulat­
ing membrane fusion, further underscoring the importance 
of calcium for the protein’s function. These results demon­
strate for the first time that otoferlin is a calcium sensor 
that can directly regulate soluble N­ethyl­maleimide sensi­
tive fusion protein attachment protein receptor–mediated 
membrane fusion reactions.
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a larger three–C2 domain construct, C2DEF, was created to as-
certain the properties of the reported smaller three–C2 domain 
splice variant. A C2ABC construct was analyzed in parallel to   
determine what the additional N-terminal three–C2 domains, found 
in the larger isoform, contribute to the function of the molecule.
Results
Otoferlin is a calcium sensor
It has been suggested that otoferlin might function as a calcium 
sensor in cochlear IHCs, outer hair cells, and vestibular cells, anal-
ogous to the role that synaptotagmin I/II play during SNARE-
mediated neurotransmitter release in neurons (Roux et al., 2006). 
Both C2 domains of synaptotagmin I bind calcium ions through 
coordination with aspartate residues located on one end of   
each C2 domain (Shao et al., 1998; Fernandez et al., 2001).   
Alignment of the primary sequence of the C2 domains of   
otoferlin with the calcium-binding aspartate residues of synap-
totagmin I reveals a lack of conservation among the first three 
N-terminal C2 domains of the protein (Fig. 1, A and B). How-
ever, C2 domains from several other proteins do not possess all 
five aspartate residues yet, in some cases, are still able to bind 
calcium (Therrien et al., 2009). Therefore, it is unclear from in-
spection of the sequence as to which domains of otoferlin, if 
any, bind calcium. To address this question, we examined the 
intrinsic fluorescence of recombinant otoferlin constructs as a 
function of calcium concentration. In several cases, the fluores-
cence spectra of aromatic amino acids within C2 domains have 
In  addition,  >16  different  nonsense  and  missense  mutations 
within the human gene encoding otoferlin have been linked to a 
type of nonsyndromic hearing loss known as DFNB9. However, 
subcellular localization studies have led to conflicting conclu-
sions. An immunogold staining study reports localization to syn-
aptic vesicles (Roux et al., 2006), whereas immunofluorescence 
indicated that otoferlin is localized predominantly in the Golgi 
and possibly in early endosomes (Schug et al., 2006; Heidrych 
et al., 2008). Thus, otoferlin may have alternative or additional 
functions, such as vesicle recycling or membrane trafficking in 
the Golgi. Recently, it was reported that point mutations within 
otoferlin resulted in plasma membrane infolding (Heidrych et al., 
2008). This suggests a role for otoferlin in the endocytosis and 
vesicle recycling and could explain why otoferlin IHC knock-
outs exhibit defects in exocytosis.
From cell-based studies, it is not entirely clear as to whether 
otoferlin contributes directly to exocytosis or is involved in sec-
ondary events up and/or downstream of synaptic vesicle fusion. 
However, it should be noted that these cellular processes place 
different functional demands on the protein, and one can thereby 
gain insight into the role of otoferlin in IHCs through in vitro 
functional studies. Specifically, if otoferlin is indeed a calcium 
sensor involved in neurotransmitter release, we would expect   
recombinant forms of the protein to bind calcium, SNAREs,   
and membranes and to accelerate SNARE-mediated membrane 
fusion in a calcium-dependent manner. In this study, we screened 
the individual otoferlin C2 domains for these properties to deter-
mine whether otoferlin operates as a calcium sensor. In addition, 
Figure 1.  Schematic diagram of full-length otoferlin   
and  the  otoferlin  fragments  used  in  this  study.  
(A) Otoferlin is composed of six tandem C2 do-
mains  followed  by  a  C-terminal  transmembrane 
domain  (TMD).  Recombinant  proteins  composed 
of either isolated C2 domains or three–C2 domain 
fragments were generated according to the amino 
acid designations listed on the right. (B) Conserva-
tion of putative calcium-binding ligands of the C2 
domains  of  otoferlin  (oto).  Synaptotagmin  I  (syt) 
C2A and C2B are listed for comparison. The num-
bers correspond to the order of the five aspartate 
residues that function as ligands in the C2A (D172, 
178,  230,  232,  and  238)  and  C2B  domains 
(D303, 309, 363, 365, 371) of synaptotagmin I 
(Sutton et al., 1995; Shao et al., 1998; Fernandez 
et al., 2001).189 Otoferlin regulates membrane fusion • Johnson and Chapman
potential shifts in calcium affinity induced by membranes, cal-
cium titration curves were generated in the presence of lipo-
somes composed of 15% DOPS, 30% POPE, and 55% POPC. 
Analogous to the liposome-free samples, all of the otoferlin 
constructs except C2A displayed increases in fluorescence in 
the presence of calcium as compared with measurements made 
in EGTA. The resultant calcium titration curves (Fig. 3, C and D) 
for the otoferlin–liposome samples show a leftward shift in 
[Ca
2+]1/2, with values ≤10 µM for all constructs tested (Table I). 
We conclude that otoferlin binds calcium via at least five of its 
six domains and that membranes increase the apparent calcium-
binding affinity of these domains.
The C2 domains of otoferlin bind  
SNARE proteins
As described in the Introduction, it has been reported that 
otoferlin associates with the t-SNARE proteins syntaxin 1 and 
SNAP-25. However, neither the specific domains of otoferlin 
that bind t-SNAREs nor the effects of calcium on binding have 
been examined. To address these issues, an immunoprecipita-
tion assay was performed using the recombinant t-SNARE 
heterodimer syntaxin1A/SNAP-25B and an anti-syntaxin anti-
body (Fig. 4, A and B). 20 µM of each otoferlin C2 domain 
was  tested  for  coimmunoprecipitation  in  the  presence  of   
0.1 mM EGTA or 1 mM calcium. Although all six domains 
immunoprecipitated with the t-SNARE heterodimer, four of 
the isolated domains, C2C, C2D, C2E, and C2F, displayed 
been shown to be sensitive to the binding of calcium (Nalefski 
et al., 2001).
As an initial screen for calcium binding, the fluorescence 
spectra of recombinant otoferlin constructs were measured in 
the presence either 0.1 mM EGTA or 1 mM calcium. As shown 
in Fig. 2, addition of calcium resulted in significant increases in 
the fluorescence intensity of isolated C2B, C2C, C2D, C2E, and 
C2F,  but  not  C2A.  In  addition,  the  recombinant  fragments 
C2ABC and C2DEF also exhibited significant increases in fluor-
escence in response to calcium. For several otoferlin fragments, 
we also detected a shift in the emission wavelength maxima 
(max). These shifts were most prominent in the larger three–C2 
domain fragments, with the N-terminal C2ABC fragment dis-
playing a noticeable blue shift and the C2DEF a slight red shift. 
Subsequent  calcium  titrations  resulted  in  sigmoidal  dose- 
response curves for both the larger constructs and the isolated 
C2 domains (Fig. 3, A and B). From these plots, [Ca
2+]1/2 values 
were determined (Table I). To test the specificity of calcium 
binding, the titration experiments were repeated in the presence 
of 0.75 mM magnesium. Magnesium had no effect on the cal-
cium dose-responses, indicating that binding was specific for 
calcium (unpublished data).
Many C2 domains bind to membranes, with varying affin-
ity and lipid headgroup specificity, as an integral part of their 
function (Nalefski et al., 2001). Binding is often calcium depen-
dent, with the cation, protein, and lipid forming a complex with 
an enhanced protein–calcium-binding affinity. To probe for   
Figure  2.  Normalized  fluorescence  emis-
sion spectra of native aromatic side chains of 
otoferlin in the presence of 0.1 mM EGTA or   
1 mM calcium. 1 µM purified otoferlin fragments 
were  excited  at  280  nm  and  the  emission 
spectra collected from 290 to 380 nm. Repre-
sentative spectra for each domain under EGTA 
or calcium conditions are shown. The traces 
are representative data from four independent 
trials. FI, fluorescence intensity.JCB • VOLUME 191 • NUMBER 1 • 2010   190
The C2 domains of otoferlin bind  
to lipid membranes
The ability of otoferlin to bind membranes has not been ad-
dressed. Because synaptotagmin I operates at least in part by 
binding to membranes, we tested each otoferlin C2 domain for 
membrane-binding activity in the presence of EGTA or calcium 
using a liposome coflotation assay. In this assay, 15% DOPS, 
55% POPC, and 30% POPE liposomes in a solution containing 
the C2 domain of interest are floated through a density gradi-
ent, carrying along with them any bound protein. SDS-PAGE is 
performed on the collected sample to assay for protein bound 
to the liposomes. Unlike the aforementioned fluorescence mea-
surements, this assay directly measures the binding of protein 
to liposomes instead of the shift in calcium affinity. Although 
all six C2 domains bound to liposomes in the presence of 1 mM   
free calcium (Fig. 4 C), the C2A, C2B, and C2C domains also 
bound to some extent under calcium-free conditions. We also 
note that the larger three–C2 domain fragments of otoferlin 
directly associated with liposomes in EGTA, and binding was 
enhanced by addition of calcium (Fig. S1 C).
Otoferlin aggregates liposomes  
in a calcium-dependent manner
A previous study of synaptotagmin demonstrated its ability to ag-
gregate membranes in a calcium-dependent manner (Popoli and 
Paternò, 1992), and this activity has been proposed to facilitate 
membrane fusion. Given the hypothesized role of otoferlin in exo-
cytosis, we sought to determine whether otoferlin can also   
calcium-promoted binding activity (Fig. 4, A and B). Binding 
of the other two domains, C2A and C2B, was not enhanced by 
calcium. These results are consistent with a previous GST 
pull-down study, which concluded that C2A bound in a calcium-
independent manner to syntaxin, whereas the SNARE-binding 
activity of C2F was regulated by calcium (Ramakrishnan   
et al., 2009).
We also probed for interactions between native otoferlin 
and ternary SNARE complexes. Coimmunoprecipitation assays   
using whole brain detergent extracts and GST pull-down ex-
periments using recombinant synaptobrevin 2 revealed that 
otoferlin binds ternary syntaxin 1/SNAP-25/synaptobrevin 2 
complexes but does not directly interact with synaptobrevin   
(Fig. S1, A and B), which is analogous to synaptotagmin 1 
(Earles et al., 2001).
Table I.  [Ca
2+]1/2 values for each C2 domain of otoferlin
C2 domain  Liposomes [Ca
2+]1/2 + Liposomes [Ca
2+]1/2
µM µM
C2A ND ND
C2B 21.1 ± 1.1 6.7 ± 0.3
C2C 15.1 ± 2.0 5.4 ± 0.1
C2D 17.0 ± 1.1 4.4 ± 0.1
C2E 25.0 ± 1.50 7.5 ± 0.8
C2F 21.1 ± 2.0 10 ± 0.2
C2ABC 15.4 ± 0.60 2.0 ± 0.1
C2DEF 14.7 ± 0.60 1.9 ± 0.8
Figure 3.  Calcium-dependent changes in otoferlin fluorescence. (A and B) Normalized plots of the emission intensities of 1 µM of the three–C2 domain 
fragments C2ABC and C2DEF (A) and 1 µM of the isolated C2 domains C2B, C2C, C2D, C2E, and C2F (B) as a function of increasing calcium concen-
tration in the absence of liposomes. (C and D) Calcium titrations of C2ABC, C2DEF (C), and each isolated C2 domain of otoferlin (D) in the presence of 
liposomes composed of 15% PS, 55% PC, and 30% PE. Error bars indicate mean ± SD (n = 4).191 Otoferlin regulates membrane fusion • Johnson and Chapman
and t-SNARE proteoliposomes (Fig. 5, A and B). The otoferlin 
fragments were incubated with a 1:2 ratio of the v- and t-SNARE 
proteoliposomes for 20 min at 37°C in 0.1 mM EGTA followed 
by the injection of calcium to a final concentration of 1 mM 
(Fig. 5, A and B, arrows). Upon addition of calcium, both frag-
ments of otoferlin induced a marked increase in the rate and final 
extent of fusion, as indicated by dequenching of NBD fluores-
cence. In the absence of calcium, neither otoferlin fragment en-
hanced SNARE-mediated fusion to any appreciable extent. In the 
absence of otoferlin, only a slow SNARE-dependent linear in-
crease in fusion was observed, which is consistent with a previ-
ous study of reconstituted SNARE-mediated membrane fusion 
(Chicka et al., 2008). As a final control, and to distinguish be-
tween full and hemi fusion, we quenched the fluorescence of the 
outer leaflet with dithionite and monitored the fate of the inner 
leaflet during reconstituted fusion reactions. After dithionite treat-
ment, dequenching of the inner leaflet was observed, demonstrat-
ing that full fusion occurred for all of the otoferlin constructs 
reported in this study (unpublished data).
Titration of the otoferlin fragments led to an increase in the 
rate and extent of fusion until saturation was achieved (Fig. 5,   
A and B), and calcium dose-response experiments revealed [Ca
2+]1/2 
values of 109 µM and 131 µM for C2ABC and C2DEF, respec-
tively  (Fig.  S2). To  ensure  that  fusion  proceeded  through  a 
SNARE-dependent pathway, assays were also conducted in the 
presence of either the soluble cytoplasmic domain of synapto-
brevin (cd-syb) or a soluble form of the t-SNARE heterodimer 
(cytoplasmic domain of the t-SNARE heterodimer [cd–t-SNARE]), 
which will prevent proper trans-SNARE pairing of the v- and   
t-SNARE  proteoliposomes.  Both  cd-syb  and  cd–t-SNARE  re-
duced the final extent of fusion (Fig. 5, C and D), indicating 
that otoferlin-accelerated fusion proceeds through a SNARE- 
dependent pathway and that otoferlin alone cannot induce   
aggregate  membranes.  Membrane  aggregation  was  assayed  by 
monitoring changes in the OD400 of liposomes over time (Fig. 4 D). 
Although the addition of isolated or multi–C2 domain forms of 
otoferlin to a liposome sample in EGTA did not result in an appre-
ciable increase in the OD400 of the sample over the course of 5 min, 
addition of 1 mM free calcium resulted in a significant increase in 
the OD400 for five of the six isolated C2 domains tested and for both 
larger three–C2 domain fragments (Fig. 4 D). This increased OD400 
value remained stable over the monitoring period (15 min) and 
was reversed by addition of excess EGTA. Among the C2 domains 
tested, only C2A failed to induce significant changes in the OD400. 
Addition of calcium to protein-free liposome solutions did not   
result in any significant degree of aggregation.
Calcium/otoferlin accelerates SNARE-
mediated membrane fusion
Using an in vitro reconstituted system, the in vivo effects of 
synaptotagmin  on  SNARE-mediated  membrane  fusion  have 
been recapitulated (Tucker et al., 2004; Bhalla et al., 2006; Stein 
et al., 2007; Chicka et al., 2008; Gaffaney et al., 2008; Xue et al., 
2008). In this system, v-SNARE proteoliposomes containing 
membrane-bound NBD and rhodamine fluorescence resonance 
energy transfer pairs are mixed with t-SNARE proteoliposomes 
that do not contain fluorophores. Fusion between v- and t-SNARE 
proteoliposomes results in lipid mixing of the two proteoliposomes 
and dilution of the fluorescence resonance energy transfer pair. 
This dilution increases the distance between the donor and acceptor, 
resulting in dequenching of the NBD. Using this system, we 
asked whether otoferlin can accelerate SNARE-mediated mem-
brane fusion and whether calcium modulates otoferlin’s putative 
function during fusion.
We first screened the three–C2 domain constructs (C2ABC 
and C2DEF) for their ability to regulate fusion between v-SNARE 
Figure 4.  Coimmunoprecipitation of t-SNARE heterodimers with the isolated C2 domains of otoferlin. (A) The assays were performed using 20 µM of each 
C2 domain using an anti-syntaxin monoclonal antibody. T denotes the total C2 domain loaded into the sample, and Ca and E denote the presence of 1 mM 
calcium or 0.1 mM EGTA, respectively. H-chain denotes the heavy chain of the anti-syntaxin antibody (HPC-1). (B) Quantitation of the coimmunoprecipitation 
data using densitometry. (C) Representative gel in which each isolated C2 domain was assayed for its ability to cofloat with vesicles in an Accudenz gradient 
in the presence of 0.1 mM EGTA or 1 mM free calcium. (D) Calcium-triggered C2 domain–induced liposome aggregation as measured by OD400 is shown. 
Turbidity of samples containing liposomes was monitored in either 1 mM free calcium or 0.1 mM EGTA. Error bars indicate mean ± SD (n = 3).JCB • VOLUME 191 • NUMBER 1 • 2010   192
30 µM, C2A failed to accelerate SNARE-mediated fusion re-
gardless of the presence of calcium (Fig. 7).
Point mutations disrupt the function of the 
C2 domains of otoferlin
A previously reported isoleucine to asparagine mutation in the 
C2B domain of otoferlin was found to induce severe hearing 
loss in mouse models (Longo-Guess et al., 2007). Although the 
structure of this domain is not currently known, sequence align-
ment with other C2 domains suggests that this mutation lies 
within one of the  strands of the domain. A previous study 
suggested that this mutation may disrupt folding, resulting in 
decreased stability and increased turnover rates within the cell 
(Longo-Guess et al., 2007). To investigate the functional prop-
erties of this mutant, we introduced the I318N mutation into 
the isolated C2B domain. Fluorescence spectra of the wild-type 
liposome fusion. We also note that otoferlin could not promote 
membrane fusion of liposomes that lacked v- or t-SNARE pro-
teins (Fig. 5 D). Together, these data demonstrate for the first 
time that both the N- and C-terminal halves of otoferlin can 
stimulate SNARE-mediated membrane fusion in a calcium- 
promoted manner.
We next tested whether otoferlin can do “work” on SNARE 
proteins. A previous study has shown that syntaxin 1 and SNAP-25 
must be preassembled before reconstitution to mediate fusion 
with v-SNARE proteoliposomes (Bhalla et al., 2006). However, 
calcium and synaptotagmin I can drive folding of soluble 
SNAP-25 onto reconstituted syntaxin, resulting in fusion activ-
ity (Bhalla et al., 2006). We repeated these experiments and, as 
shown in Fig. 6, appreciable membrane fusion was not observed 
when syntaxin was reconstituted but SNAP-25 was added in a 
soluble form. However, in the presence of either half of otoferlin, 
C2ABC or C2DEF, fusion was observed upon addition of   
calcium; in the absence of calcium, fusion was not observed   
under any conditions (Fig. 6). These findings provide functional 
evidence that calcium/otoferlin regulates the folding and activ-
ity of SNARE proteins.
As a final survey of otoferlin’s functional properties, we 
conducted membrane fusion assays with isolated C2 domains to 
determine which ones were responsible for the observed stimu-
latory effect observed in the larger fragments (Fig. 7 and Fig. S3). 
C2  domain  concentrations  ranging  from  0  to  30  µM  were   
titrated into the fusion assay, as detailed for the aforementioned 
three–C2 domain fragments. Upon the addition of calcium at   
t = 20 min, membrane fusion was observed for reactions that con-
tained C2B, C2C, C2D, C2E, and C2F to yield a final extent of 
fusion of 20% at the maximum concentrations tested. Inter-
estingly, examination of the shape of the fusion curves reveals 
differences in the kinetics of fusion, with C2E showing slower 
kinetics relative to isolated domains C2B, C2C, C2D, and C2F 
(Fig. 7). As shown in Fig. 7, the use of SNARE-free liposomes 
resulted in the total absence of fusion for all five C2 domains, 
again demonstrating the requirement for SNAREs (Fig. 7). At up to 
Figure 5.  Otoferlin stimulates SNARE-mediated 
proteoliposome  fusion  in  a  calcium-dependent 
manner. Fusion experiments were performed using   
donor  v-SNARE  proteoliposomes  and  t-SNARE 
acceptor  proteoliposomes  with  varying  concen-
trations of recombinant otoferlin fragments. The 
components were incubated together for 20 min 
at 37°C in the presence of 0.1 mM EGTA. At t = 
20 min, calcium was added to a final concentration 
of 1 mM. (A and B) Both C2ABC (A) and C2DEF 
(B)  stimulated  SNARE-mediated  proteoliposome 
fusion in response to calcium. (A and B) E indi-
cates that the experiment was performed under 
EGTA conditions. (C and D) Mean value for the 
extent  of  fusion  expressed  as  a  percentage  of 
maximum fluorescence intensity after addition of 
detergent for 10 µM C2ABC (C) and C2DEF (D) 
under the indicated conditions. Fusion was attenu-
ated by addition of cd-syb or cd–t-SNARE. Error 
bars represent SD (n = 3).
Figure 6.  Calcium/otoferlin enables t-SNAREs, which have not been   
preassembled into heterodimers, to drive membrane fusion. (A) Fusion   
assays were conducted using reconstituted syntaxin 1 and synaptobrevin 2 
vesicles in the presence of 15 µM soluble SNAP-25 and 4 µM otoferlin. 
(B) Either half of otoferlin, C2ABC, or C2DEF was sufficient to accelerate 
membrane fusion using soluble SNAP-25. In the absence of calcium or 
otoferlin, fusion was not observed. E indicates that the experiment was 
performed under EGTA conditions.193 Otoferlin regulates membrane fusion • Johnson and Chapman
roles for the protein, including possible contributions to Golgi 
and endosomal trafficking. In this study, we have conducted   
direct measurements using reduced in vitro approaches, includ-
ing a reconstituted SNARE-mediated membrane fusion system, 
to test otoferlin’s functional properties. These experiments are 
advantageous in that they are free from the ambiguities that can 
arise because of the complexity of cellular systems and are thus 
able to directly address otoferlin’s ability to act as a calcium-
activated regulator of membrane fusion.
Otoferlin senses micromolar 
concentrations of calcium
By monitoring the fluorescence spectra of the endogenous aro-
matic residues of otoferlin, we determined that at least five of 
the six C2 domains of the protein bind calcium with [Ca
2+]1/2 
values lower than those reported for synaptotagmin I (Davis et al., 
1999; Fernandez et al., 2001; Nalefski et al., 2001). Only C2A 
failed to exhibit any change in fluorescence in the presence of 
calcium. Interestingly, we observed significant calcium-induced 
shifts in the emission maxima for several of the C2 domains and 
both three–C2 domain fragments. Because it has been well es-
tablished that the emission spectra of tryptophan is highly sensi-
tive to the polarity of its local environment (Vivian and Callis, 
2001), we suspect that the shifts are caused by changes in the 
degree of exposure of the aromatic amino acid side chains to 
solvent. Finally, calcium titrations in the presence of membranes 
resulted in left-shifted [Ca
2+]1/2 values as compared with sam-
ples lacking membranes. Therefore, the presence of membranes 
enhances the affinity of the otoferlin C2 domains for calcium. 
We note that the apparent affinities, measured in the presence of 
membranes, are also greater than those previously reported for 
(WT) and mutant domain differed markedly (Fig. 8 A), sug-
gesting a perturbation of the tertiary structure, and the fluores-
cence spectrum of the I318N mutant was unaffected by calcium   
(Fig. 8 A), signifying a loss of calcium-sensing activity. As a 
second test of functionality, the mutant C2B domain was as-
sayed for its ability to aggregate membranes; in contrast to WT, 
the mutant failed to aggregate membranes in the presence of   
1 mM calcium (Fig. 8 B). Lastly, at equivalent 30 µM C2 do-
main concentrations, the WT C2B domain accelerated SNARE- 
mediated fusion in response to added calcium, whereas the 
I318N C2B mutant failed to have any effect on fusion in the 
presence of EGTA or 1 mM calcium (Fig. 8 C).
Finally, we studied the effects of mutating two of the putative 
calcium-binding residues in the C2C domain of otoferlin (Fig. S4). 
These mutations should abrogate the calcium-binding activity of 
the C2 domain and therefore eliminate calcium-triggered stimula-
tion of SNARE-mediated membrane fusion. Indeed, although 
circular dichroism measurements indicated that the mutant pro-
tein was properly folded (unpublished data), we found that this 
mutant did not accelerate membrane fusion in the presence or 
absence of calcium (Fig. S4).
Discussion
The goal of this study was to ascertain whether otoferlin is   
indeed a calcium sensor capable of directly controlling SNARE- 
mediated membrane fusion reactions. Although a previous study 
of IHCs found otoferlin to be essential for calcium-evoked ves-
icle release (Roux et al., 2006), a recent immunofluorescence 
study failed to detect colocalization between otoferlin and hair 
cell synaptic ribbons, and Schug et al. (2006) suggested alternative 
Figure 7.  The isolated C2 domains of otoferlin 
stimulate membrane fusion. Titrations of each 
isolated C2 domain, from 0 to 30 µM, demon-
strate the ability of the otoferlin C2 domains 
C2B, C2C, C2D, C2E, and C2F to stimulate 
fusion  between  v-  and  t-SNARE  proteolipo-
somes. The isolated C2 domains failed to stim-
ulate  membrane  fusion  between  protein-free 
(PF) liposomes. E indicates that the experiment 
was performed under EGTA conditions.JCB • VOLUME 191 • NUMBER 1 • 2010   194
and calcium sensitivity of otoferlin may be tuned via preferen-
tial expression of long or short forms of the protein.
The otoferlin C2 domains bind  
and aggregate lipid membranes
A hallmark characteristic of many C2 domains concerns their 
ability to bind to lipid bilayers. In addition, it has been shown 
that synaptotagmin I operates at least in part by penetrating and 
bending membranes (Martens et al., 2007; Hui et al., 2009). 
However the question of whether otoferlin can bind lipid mem-
branes had not been addressed in any previous study. Using 
a coflotation assay, we found that all six C2 domains bound 
to  liposomes  composed  of  POPC/DOPS/POPE.  Membrane-
binding activity was promoted by calcium for the C2C, C2D, 
CD2E, and C2F domains. C2A and C2B exhibited a strong 
synaptotagmin I (Brose et al., 1992; Davis et al., 1999; Nalefski 
et al., 2001).
All six C2 domains of otoferlin bind  
SNARE proteins
Using an immunoprecipitation procedure, we found that all six 
otoferlin C2 domains bound to syntaxin1A/SNAP-25 hetero-
dimers. This finding marks the first time all six domains have been 
assayed for SNARE-binding activity and suggests that each of 
these domains may function to modulate SNARE activity. In-
terestingly, the C-terminal C2 domains C2C, C2D, C2E, and 
C2F were more responsive to calcium in terms of their SNARE-
binding properties than the N-terminal C2A and C2B domains. 
Given that a splice variant containing only the three C-terminal 
domains has been reported, the stoichiometry, binding affinity, 
Figure 8.  A pathological isoleucine to asparagine missense mutation disrupts the structure and function of the C2B domain of otoferlin. (A) The fluores-
cence spectra of endogenous aromatic residues of the isolated WT (left) and I318N (right) mutant C2B domain differ in their spectral profiles. Although 
a notable difference in the fluorescence intensity (FI) of WT C2B is observed in 0.1 mM EGTA versus 1 mM calcium conditions, the spectra of the I318N 
mutant shows no discernable change in fluorescence in response to calcium. (B) The membrane aggregation activity of C2B is disrupted by the I318N 
mutation. After injection of protein at t = 5 min, calcium was added at t = 0 min to a final concentration of 1 mM. OD400 measurements for the WT C2B 
(left) and I318N (right) reveal that the point mutation abrogates calcium-triggered C2B-mediated liposome aggregation. The OD400 values after addition 
of calcium were 0.11 ± 0.02 for WT and 0.02 ± 0.01 for the mutant C2B (n = 3). (C) Reconstituted fusion assays performed in the presence of WT or 
I318N mutant C2B. After the addition of 1 mM free calcium, WT C2B accelerated SNARE-mediated fusion, whereas the I318N failed to enhance the rate 
or extent of fusion.195 Otoferlin regulates membrane fusion • Johnson and Chapman
isoleucine is essential for proper tertiary structure, and substitu-
tion with an asparagine results in the loss of activity of the C2B 
domain. As a further control, two aspartate residues were sub-
stituted with alanines in the C2C domain, and this mutant pro-
tein  failed  to  stimulate  SNARE-mediated  membrane  fusion 
reactions in response to calcium, thus confirming the finding 
that C2 domains from otoferlin are bona fide functional calcium-
sensing modules.
In  summary,  we  have  demonstrated  that  otoferlin  pos-
sesses the ability to bind calcium, membranes, and SNAREs 
and is able to directly accelerate SNARE-mediated membrane 
fusion. However, several questions related to otoferlin and its 
function have yet to be addressed. One critical issue concerns 
the lipid-binding specificities of each C2 domain. This question 
is of particular interest because the lipid specificities of many 
C2 domains are often tailored to their target membranes, and 
thus, insight into this specificity could shed light as to where, 
within cells, otoferlin functions.
Materials and methods
Materials and reagents
Synthetic DOPS (1,2-dioleoyl-sn-glycero-3-phospho-l-serine), DOPC (1,2- 
dioleoyl-sn-glycero-3-phosphocholine),  POPC  (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine),  POPE  (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
ethanolamine),  dansyl-PE  (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N- 
(5-dimethylamino-1-naphthalenesulfonyl)), NBD-PE (1,2-dipalmitoyl-sn-
glycero-3-phospho-ethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)), and 
rhodamine-PE (N-(lissamine rhodamine B sulfonyl)-1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine) were purchased from Avanti Polar Lipids, Inc.   
Affinity  media  Ni
2+-Sepharose  high  performance  beads  were  obtained 
from GE Healthcare. Accudenz was obtained from Accurate Chemical & 
Scientific Corporation.
Plasmids and protein purification
cDNA-encoding mouse otoferlin was provided by C. Petit (Institut Pasteur, 
Paris, France). All otoferlin fragments were subcloned into pTrcHisA or 
PGEX expression vectors (Invitrogen) via BamHI and EcoRI and expressed 
in Escherichia coli as fusion proteins. Purification was performed essen-
tially as described previously (Gaffaney et al., 2008). Point mutations were 
prepared using a site-directed mutagenesis kit (QuikChange; Agilent Tech-
nologies). Plasmids for mouse synaptobrevin 2 and the t-SNARE hetero-
dimer (mouse SNAP-25B and rat syntaxin 1A) were provided by J.E. Rothman 
(Yale University, New Haven, CT). Synaptobrevin 2 and the t-SNARE com-
plex were expressed as previously described (Gaffaney et al., 2008).
Protein-free and SNARE-bearing liposomes
Reconstitution of SNARE proteoliposomes was performed as previously 
reported (Gaffaney et al., 2008). Synaptobrevin 2 v-SNARE proteolipo-
somes were composed of 30 mol% POPE, 52% POPC, 15% DOPS, 1.5% 
rhodamine-PE (acceptor), and 1.5% NBD-PE (donor). Syntaxin 1A/SNAP-
25B t-SNARE heterodimer proteoliposomes were composed of 30 mol% 
POPE, 55 mol% POPC, and 15 mol% DOPS. Proteoliposomes contained 
100 copies of SNARE proteins per liposome. Protein-free liposomes were 
formed via extrusion using a lipid mixture matching that of the t-SNARE 
proteoliposomes as described previously (Hui et al., 2009).
Flotation assays
Flotation assays using protein-free extruded liposomes were performed using 
procedures described previously (Bhalla et al., 2006; Gaffaney et al., 2008). 
All otoferlin–liposome-binding reactions were performed in either 0.1 mM 
EGTA or 1 mM free calcium in Hepes buffer (10 mM Hepes and 100 mM 
NaCl, pH 7.5). 15 µM otoferlin was incubated with liposomes before mixing 
with an Accudenz density medium. The mixture was overlaid with decreasing 
amounts of Accudenz (35%, 30%, and 0%). After centrifugation, the lipo-
somes floated to the 0/30% Accudenz interface along with any bound frag-
ments of otoferlin. The sample at the interface was collected from the Accudenz 
interface, resolved by SDS-PAGE, and stained with Coomassie blue. Gels were 
imaged using a flatbed scanner and processed using Illustrator (Adobe).
calcium-independent component of binding. Surprisingly, de-
spite its ability to bind membranes in the absence of calcium, 
C2B still required calcium to induce liposome aggregation, as 
did C2C, C2D, C2E, and C2F. In contrast, the N-terminal C2A 
domain failed to aggregate membranes under any of the condi-
tions tested. Interestingly, synaptotagmin I can also aggregate 
membranes through its C2 domains (Popoli and Paternò, 1992; 
Bhalla et al., 2006; Gaffaney et al., 2008). It is possible that 
all membrane fusion–accelerating C2 domains operate in part 
through a membrane aggregation mechanism.
Otoferlin stimulates SNARE-mediated 
membrane fusion in response to calcium
Using a reconstituted membrane fusion assay, we found that 
five of the six C2 domains accelerate membrane fusion in the 
presence of calcium but not under EGTA conditions. Fusion 
was SNARE dependent in that otoferlin failed to induce lipid 
mixing in the presence of cd-syb, cd–t-SNARE, or when protein-
free liposomes were used in the fusion assay. These results are 
what one would expect from a calcium sensor for membrane fusion 
and qualitatively agree with previous work focused on synapto-
tagmin I (Tucker et al., 2004; Chicka et al., 2008; Gaffaney et al., 
2008). However, otoferlin is distinct from synaptotagmin I in 
that it contains multiple fusion-active C2 domains linked in se-
ries and possesses longer linkers between each C2 domain that 
may endow otoferlin with flexibility and reach. When combined 
with the findings that otoferlin binds myosin VI and calcium 
channels (Heidrych et al., 2009; Ramakrishnan et al., 2009),   
it is tempting to speculate that the protein links vesicles to 
SNAREs and calcium channels in a docked and primed state. 
Given our finding that most of the C2 domains of otoferlin can 
directly regulate membrane fusion and the recent proposal that 
synaptic vesicles bound to ribbons are capable of compound fusion 
(Matthews and Sterling, 2008), the scenarios by which otoferlin 
might operate become numerous.
Point mutations disrupt the function  
of otoferlin C2 domains
Pathological missense mutations in the C2C (Mirghomizadeh   
et al., 2002), C2D (Tekin et al., 2005), and C2F domains (Migliosi 
et al., 2002) of otoferlin have been linked to profound deafness 
in several human patients. Interestingly, in each case, a single 
amino acid change in a single C2 domain results in deafness; in 
some cases, this appears to be caused by degradation of the entire 
protein in response to misfolding of single domains. For example, 
a recently reported missense mutation in the C2B domain resulted 
in  the  loss  of  otoferlin  and  deafness  in  mice  (Longo-Guess   
et al., 2007). We found that this I318N mutation gave rise to in-
trinsic fluorescence that was altered as compared with the WT 
C2 domain. The emission maxima and intensity of fluorescence 
spectra are highly sensitive to the environment of aromatic side 
chains of the protein, and the fact that the mutant protein spec-
trum differs from WT suggests alteration in the tertiary struc-
ture of the domain. Furthermore, no change in fluorescence was 
observed upon the addition of calcium to the I318N mutant nor 
was the mutant capable of accelerating SNARE-mediated mem-
brane fusion in the presence of calcium. Thus, the conserved JCB • VOLUME 191 • NUMBER 1 • 2010   196
membrane fusion. Fig. S4 shows that neutralization of the putative calcium 
ligands D515 and 517 in the C2C domain of otoferlin abolishes calcium-
stimulated  fusion.  Online  supplemental  material  is  available  at  http://
www.jcb.org/cgi/content/full/jcb.201002089/DC1.
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Fusion assays
All fusion assays were conducted using a 96-well plate reader (460-nm   
excitation and 538-nm emission; BioTek Instruments, Inc.) as described   
previously with minor modifications (Chicka et al., 2008; Gaffaney et al., 
2008). Fusion samples contained a total volume of 75 µl with 30 µl puri-
fied t-SNARE proteoliposomes, 15 µl purified v-SNARE proteoliposomes, 
0.1 mM EGTA, and 0–30 µM otoferlin protein in Hepes buffer. For samples 
in which calcium was added, the free calcium concentration was 1 mM. At 
the end of each run, 0.5% wt/vol n-dodecylmaltoside was added to deter-
mine the maximal dequenched NBD signal. Raw fluorescence was normal-
ized  to  obtain  the  percentage  of  maximum  fluorescence  as  described 
previously (Chicka et al., 2008; Gaffaney et al., 2008).
Protein fluorescence measurements
Fluorescence measurements of native aromatic residues in various otoferlin 
fragments were performed using a fluorometer (QM-1; Photon Technology 
International) in Hepes buffer plus 0.1 mM EGTA using liposomes with a 
lipid composition matching that of the t-SNARE liposomes. For the calcium 
titrations experiments, a Hepes-buffered stock solution of calcium chloride 
was used, and the concentration of free calcium was determined using 
WebMaxC (www.stanford.edu/~cpatton/webmaxcS.htm).
Immunoprecipitation assay
Immunoprecipitation experiments were performed as described previously 
(Hui et al., 2009) with modifications. 10 µM t-SNARE heterodimer was in-
cubated with 20 µM otoferlin C2 domain in Hepes buffer plus 0.5% Triton 
X-100 for 1 h on ice in the presence of 0.1 mM EGTA or 1 mM calcium. 
t-SNAREs were precipitated through the addition of 3 µl of a monoclonal 
antibody directed against syntaxin (HPC-1) that was provided by R. Jahn 
(Max Planck Institute, Gottingen, Germany), followed by the addition of 
40 µl protein G–Sepharose Fast Flow bead slurry (GE Healthcare). After 
1 h, beads were collected by centrifugation and washed four times. The 
proteins in each sample were resolved via SDS-PAGE and visualized by 
staining with Coomassie blue. Gels were digitized using a scanner and 
processed using Illustrator.
Whole  brain  lysate  immunoprecipitation  assays  were  performed   
using rat brain detergent extracts that were prepared as described pre-
viously (Chapman et al., 1995; Lewis et al., 2001). 1% Triton X-100 was 
used for solubilization. Immunoprecipitation experiments were performed 
as described previously (Bai et al., 2004). For syntaxin 1A immuno-
precipitation, the HPC-1 antibody was used. Subsequent immunoblots against 
otoferlin  used  a  monoclonal  anti-otoferlin  provided  by  S.  Safieddine   
(Université Pierre et Marie Curie, Paris, France). For otoferlin immuno-
precipitation, an anti-otoferlin antibody obtained from Abcam was used 
followed by immunoblotting with the HPC-1 antibody to detect syntaxin 1A. 
Chemiluminescence film (Research Products International Corp.) was used 
to visualize the blots. Blots were digitized using a desktop scanner and 
processed using Illustrator.
Turbidity measurements
Membrane aggregation experiments were made by monitoring OD400 values 
using a UV-visible spectrophotometer (BioSpec-1601; Shimadzu Corpora-
tion). 500 µl samples contained liposomes (1 mM lipid) composed of 55% 
POPC/15%  DOPS/30%  POPE  plus  the  indicated  otoferlin  fragment  in 
Hepes buffer and 100 µM EGTA; calcium was added to a final concentra-
tion of 1 mM as indicated in Figs. 1–8.
Pull-down assays
GST-pull  down  assays  were  performed  as  described  previously  using   
80 µg bead-immobilized GST-C2ABC or GST-C2DEF (Lewis et al., 2001; 
Dong et al., 2003). In brief, SNARE complexes were formed by incubat-
ing 50 µM t-SNARE heterodimer and 50 µM synaptobrevin 2 overnight at 
4°C. The SNARE complexes were incubated with GST-otoferlin in a binding 
buffer composed of 10 mM Hepes, 100 mM NaCl, 0.5% Triton X-100, 
and either 0.1 mM EGTA or 1 mM calcium. After 1 h, the beads were 
washed three times with binding buffer, and the sample was treated with 
SDS sample buffer, subjected to SDS-PAGE, and visualized by immunoblot-
ting. For blotting, the HPC-1 anti-syntaxin antibody was used. Chemilumines-
cence film was used to visualize the blots. Blots were digitized using a 
desktop scanner and processed using Illustrator.
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otoferlin-regulated  SNARE-mediated  membrane  fusion.  Fig.  S3  shows 
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